Authors


Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP

Latest:

Practice Pearls for Treatment of Respiratory Infections

Tina Tan, MD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Priya Nori, MD; Jacinda Abdul-Mutakabbir, PharmD; and Kevin Michael Reiter, MD, PA, provide key takeaways from the discussion on the treatment of respiratory viral infections.


Leanna Liu, PharmD, BCIDP, BCPS

Latest:

Amped-up Enterobacterales Debate

Demystifying clinical data for treating invasive AmpC-harboring Enterobacterales.


Mina Seo

Latest:

Impact of Inpatient Pharmacist Review of Discharge Antibiotics

A food for thought as an ambulatory antibiotic stewardship initiative.


Amy L. Brotherton, PharmD, AAHIVP, BCIDP

Latest:

Ready, Set, Cabenuva: Implementing Cabotegravir/Rilpivirine

This novel therapeutic option represents the first long-acting injectable approved for maintenance of HIV-1 suppression.


Scott Bertani

Latest:

Mpox and Concerns Around the Disease in the United States

Scott Bertani, who is the director of Advocacy of the National Coalition for LGBTQ Health, discusses what the new mpox health declarations mean to the US, which groups are high risk, and information about the vaccine to prevent the disease.


Sarah B. Minor, PharmD, MHA, BCPS-AQ ID

Latest:

The Next Generation of COVID-19 Vaccines and Boosters

Will there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?


Chelsie Derman

Latest:

Hepatitis B Vaccination Increases Survival of Patients with Chronic Liver Disease

Hepatitis B virus vaccination shown to to significantly improve survival rates for patients with chronic hepatitis C, nonalcoholic liver disease, and liver cirrhosis.


Megan E. Uehling, MD

Latest:

Barriers to Health Care Transition in Adolescents and Young Adults With Early Acquired HIV Infection

Unique challenges can affect the success of the shift from pediatric to adult care settings.


Sahil Khanna, MBBS, MS

Latest:

Tips for Talking with Patients about Fecal Microbiota Transplant for Recurrent C. difficile Infections

To close the discussion, experts on C. difficile infections discuss how they talk with patients about fecal microbiota transplantation.


Christine Slover PharmD

Latest:

Shionogi's Strategies for Addressing Antibiotic Efficacy and Resistance

Christine Slover, PharmD discussed cefiderocol's effectiveness against challenging infections, including those caused by multi-drug resistant bacteria.


Su H. Wang, MD, MPH, FACP

Latest:

Science Is Science: Navigating Clinical Trust Amid Political Shifts

Su H Wang, MD, FACP, MPH discusses combating vaccine misinformation, preventing outbreaks, and highlighting global health interconnectedness


Aaron Hamby, PharmD

Latest:

Unmasking the Infodemic: The Impact of COVID-19 Misinformation on Public Health

Social media platforms, public health agencies, and communities must join forces to stop the rapid spread of false information.


Cheryl Wood, PharmD

Latest:

New Fecal Microbiota Options for Prevention of Recurrent Clostridioides difficile

With the addition of 2 new live biotherapeutic products, a clinician reviews the application, storage and administration techniques for them.


Louise-Marie Oleksiuk, PharmD, BCPS

Latest:

Daptomycin as Frontline Therapy for MRSA Bacteremia: Has the Time Come?

Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.


Johnathone Yang, DO

Latest:

The Final Antibiotic Symphony: Harmonizing Diagnostic Accuracy with Antibiotic Treatment in Native Joint Septic Arthritis

A study underscores the microbial etiology of septic arthritis, which can guide clinicians in minimizing the use of overly broad empiric antibiotics.


Mehrnaz Sadrolashrafi, PharmD, BCCCP

Latest:

COVID-19–Associated Fungal Infections During EMCO: Review of Epidemiology, Diagnosis, and Pharmacotherapy

Examining pharmacological management in COVID-19 patients with ARDS requiring antifungal therapy during extracorporeal life support.


Zachary Hitchcock, PharmD Candidate; and J. Drew Zimmer, PharmD, BCPS, *SIDP

Latest:

Getting Help from HAL: Applying Machine Learning to Predict Antibiotic Resistance

A pair of experts assess literature on the means of interpreting hospitalized patient antibiotic resistance through machine learning.


Elliot DeHaan, MD

Latest:

Pfizer’s RSVpreF Vaccine Shows Efficacy in High-Risk Adults Aged 18-59

Study results show that the vaccine elicits a comparable immune response in high-risk adults aged 18-59 with chronic medical conditions, suggesting potential for broader vaccination efforts.


Abigail Geyer, PharmD

Latest:

Emergency Department Antimicrobial Stewardship: A Critical Area of Focus for Health Systems

As the first line of acute care, emergency departments are key stewards of antibiotics.


Cornelius (Neil) Clancy, MD

Latest:

Real-World Effectiveness of Cefiderocol in Treating Serious Gram-Negative Infections: Insights from the PROVE Study

Cornelius Clancy, MD, highlights the real-world outcomes of cefiderocol treatment for serious gram-negative bacterial infections, reporting a clinical success rate of 75% along with encouraging safety data.


Gregory P. Monohan, MD

Latest:

Sorry Ganciclovir, You’re Just Not the One for Me

Important clinical considerations to know about resistant CMV infections.




Lacy Worden, PharmD, BCIDP

Latest:

Emergency Department Antimicrobial Stewardship: A Critical Area of Focus for Health Systems

As the first line of acute care, emergency departments are key stewards of antibiotics.


Jason Hedvat, PharmD, BCIDP

Latest:

To Prophylax or not to Prophylax: Preventing CDI

Clinicians look at optimal approaches for trying to avoid Clostridioides difficile infection (CDI).


Cara Slaton, PharmD

Latest:

STAY PrEPARED: Understanding COVID-19 Pre-Exposure Prophylaxis

New therapeutics offer some hope in this emerging market.


Kayla Stover, PharmD, BCIDP, BCPS, FCCP, FIDSA

Latest:

Top 5 Tips for Teaching ID Learners

The latest article from SIDP offers a Top 5 list of how to precept a learner on an infectious disease rotation.


Brian Lu, PharmD

Latest:

Combination Antifungal for Invasive Mucormycosis: Yay or Nay?

There is limited and conflicting data regarding the role of combination antifungal therapy for treatment of invasive mucormycosis.


Mollie Tucker, MD

Latest:

Mixed Fungal Brain Abscess

Clinicians review a patient case including diagnosis, treatment, and follow-up.


Zahra Qamar, MD; Steven F. Solga, MD; and Lisa A. Spacek, MD, PhD, FIDSA

Latest:

NAFLD Is Increasingly Affecting Patients With HIV

The prevalence of this disease in this patient population is much higher than in the general public.

© 2025 MJH Life Sciences

All rights reserved.